FDA Biosimilars Program Gets Seed Money In Administration's FY '11 Budget
Executive Summary
FDA plans to spend $5.7 million in fiscal 2011 to develop drug review standards and make other preparations for an approval pathway for follow-on biologics
You may also be interested in...
FDA Funding Bill In Senate Gives Generic Drugs More, But Commissioner Less
A Senate Appropriations Committee-approved funding package would provide the Center for Drug Evaluation and Research with $5 million more than requested by the Obama administration
FDA Funding Bill In Senate Gives Generic Drugs More, But Commissioner Less
A Senate Appropriations Committee-approved funding package would provide the Center for Drug Evaluation and Research with $5 million more than requested by the Obama administration
Generic User Fees "Very High Priority" For FDA
Commissioner Hamburg is "optimistic" that industry and the agency can reach an agreement.